India's Everest Organics starts making ingredient for Merck's COVID-19 pill | Inquirer News

India’s Everest Organics starts making ingredient for Merck’s COVID-19 pill

/ 03:16 PM October 12, 2021

India's Everest Organics starts making ingredient for Merck's COVID-19 pill

FILE PHOTO: An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS

BENGALURU India’s Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of Merck & Co’s experimental antiviral drug molnupiravir to treat mild to moderate COVID-19.

Shares of Everest Organics jumped as much as 11.6% after the news came in, and were last up 9.9% at 330 rupees in a weak Mumbai market.

ADVERTISEMENT

The Indian bulk drugs manufacturer joins Divi’s Laboratories Ltd as an API maker for Merck’s experimental oral drug.

FEATURED STORIES

Merck has separately entered into voluntary licensing agreements with at least eight Indian generic drugmakers for molnupiravir, with an aim to turn the country into a manufacturing hub for the drug.

“After the successful development and commercialization of various COVID-19 drugs such as Oseltamivir, Remdesivir… Everest Organics is on its path of expansion of this portfolio,” Chief Executive Officer Srikakarlapudi Sirisha said in a statement.

Merck said on Monday it had sought U.S. emergency use authorization for the drug, putting molnupiravir on course to become the first oral antiviral medication for COVID-19.

The U.S. authorization application was based on data released earlier this month by Merck and partner Ridgeback Biotherapeutics.

The data showed molnupiravir nearly halved the risk of hospitalization or death in at-risk non-hospitalized patients with mild-to-moderate COVID-19.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, India, medicine, Merck, molnupiravir, pill

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.